Group One Trading’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-34,000
| Closed | -$43.5K | – | 8220 |
|
|
2025
Q4 | $43.5K | Sell |
34,000
-400
| -1% | -$537 | ﹤0.01% | 5716 |
|
|
2025
Q3 | $44.7K | Sell |
34,400
-6,500
| -16% | -$8.52K | ﹤0.01% | 6056 |
|
|
2025
Q2 | $49.1K | Buy |
40,900
+19,700
| +93% | +$21.8K | ﹤0.01% | 5591 |
|
|
2025
Q1 | $22.9K | Sell |
21,200
-22,600
| -52% | -$31.7K | ﹤0.01% | 5733 |
|
|
2024
Q4 | $76.7K | Buy |
+43,800
| New | +$81.6K | ﹤0.01% | 4733 |
|
|
2023
Q4 | – | Sell |
-18,300
| Closed | -$53.1K | – | 7804 |
|
|
2023
Q3 | $53.1K | Sell |
18,300
-1,600
| -8% | -$4.18K | ﹤0.01% | 5047 |
|
|
2023
Q2 | $38.4K | Buy |
+19,900
| New | +$39.3K | ﹤0.01% | 5483 |
|
|
2023
Q1 | – | Sell |
-60,000
| Closed | -$70.2K | – | 7586 |
|
|
2022
Q4 | $70.2K | Hold |
60,000
| – | – | ﹤0.01% | 4748 |
|
|
2022
Q3 | $66K | Sell |
60,000
-96,200
| -62% | -$145K | ﹤0.01% | 5167 |
|
|
2022
Q2 | $250K | Buy |
156,200
+58,400
| +60% | +$144K | ﹤0.01% | 4084 |
|
|
2022
Q1 | $351K | Buy |
97,800
+55,700
| +132% | +$192K | ﹤0.01% | 4217 |
|
|
2021
Q4 | $165K | Buy |
42,100
+4,100
| +11% | +$19.2K | ﹤0.01% | 5272 |
|
|
2021
Q3 | $250K | Buy |
38,000
+1,900
| +5% | +$12.5K | ﹤0.01% | 4935 |
|
|
2021
Q2 | $222K | Sell |
36,100
-80,000
| -69% | -$428K | ﹤0.01% | 5138 |
|
|
2021
Q1 | $525K | Buy |
116,100
+85,100
| +275% | +$467K | ﹤0.01% | 3976 |
|
|
2020
Q4 | $186K | Sell |
31,000
-6,100
| -16% | -$40.1K | ﹤0.01% | 4103 |
|
|
2020
Q3 | $276K | Buy |
37,100
+35,500
| +2,219% | +$245K | ﹤0.01% | 3393 |
|
|
2020
Q2 | $6K | Buy |
+1,600
| New | +$5.57K | ﹤0.01% | 5310 |
|
|
2019
Q2 | – | Sell |
-1,600
| Closed | -$21K | – | 5176 |
|
|
2019
Q1 | $21K | Sell |
1,600
-400
| -20% | -$4.22K | ﹤0.01% | 4010 |
|
|
2018
Q4 | $17K | Buy |
+2,000
| New | +$15.6K | ﹤0.01% | 4085 |
|
|
2016
Q3 | – | Sell |
-4,000
| Closed | -$36K | – | 4720 |
|
|
2016
Q2 | $36K | Buy |
+4,000
| New | +$37.6K | ﹤0.01% | 3498 |
|
|
2016
Q1 | – | Sell |
-10,400
| Closed | -$112K | – | 4760 |
|
|
2015
Q4 | $112K | Sell |
10,400
-300
| -3% | -$2.95K | ﹤0.01% | 2913 |
|
|
2015
Q3 | $87K | Buy |
+10,700
| New | +$168K | ﹤0.01% | 3136 |
|
|
2015
Q2 | – | Sell |
-21,800
| Closed | -$918K | – | 5004 |
|
|
2015
Q1 | $918K | Sell |
21,800
-2,500
| -10% | -$98.8K | 0.01% | 1150 |
|
|
2014
Q4 | $820K | Buy |
24,300
+13,200
| +119% | +$374K | 0.01% | 1192 |
|
|
2014
Q3 | $272K | Buy |
11,100
+1,200
| +12% | +$33.7K | ﹤0.01% | 2132 |
|
|
2014
Q2 | $291K | Buy |
9,900
+500
| +5% | +$16K | ﹤0.01% | 2074 |
|
|
2014
Q1 | $414K | Sell |
9,400
-21,600
| -70% | -$950K | 0.01% | 1790 |
|
|
2013
Q4 | $1.19M | Buy |
31,000
+1,000
| +3% | +$29.5K | 0.02% | 986 |
|
|
2013
Q3 | $658K | Buy |
+30,000
| New | +$589K | 0.01% | 1369 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Group One Trading's LAB Position: Q1 2026 in Review
Group One Trading reduced its Standard BioTools (LAB) stake by 99% in Q1 2026, selling an estimated $32.1K and leaving 214 shares worth $197. The position accounts for ﹤0.01% of the portfolio, ranked #7393.
Group One Trading first reported a position in LAB in Q3 2013 and has held it in 31 quarters since. The position peaked at $1.43M in Q4 2013. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Group One Trading held 214 shares of Standard BioTools worth $197 as of Q1 2026.
- Group One Trading sold 26,492 Standard BioTools shares in Q1 2026, an estimated $32.1K.
- Standard BioTools made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7393 holding.
- Group One Trading first reported a position in Standard BioTools in Q3 2013 and has held it in 31 quarters since.
- Group One Trading's Standard BioTools position peaked at $1.43M in Q4 2013.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.